353 related articles for article (PubMed ID: 31824416)
21. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
22. Acanthosis nigricans, insulin resistance and cutaneous virilism.
Barth JH; Ng LL; Wojnarowska F; Dawber RP
Br J Dermatol; 1988 May; 118(5):613-9. PubMed ID: 3293647
[TBL] [Abstract][Full Text] [Related]
23. Association of metabolic syndrome and hidradenitis suppurativa.
Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
[TBL] [Abstract][Full Text] [Related]
24. Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities.
Lim ZV; Oon HH
Ann Dermatol; 2016 Apr; 28(2):147-51. PubMed ID: 27081259
[TBL] [Abstract][Full Text] [Related]
25. "Inflammatory skin march" in atopic dermatitis and psoriasis.
Furue M; Kadono T
Inflamm Res; 2017 Oct; 66(10):833-842. PubMed ID: 28620798
[TBL] [Abstract][Full Text] [Related]
26. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome and systemic lupus erythematosus: the connection.
Mok CC
Expert Rev Clin Immunol; 2019 Jul; 15(7):765-775. PubMed ID: 31094570
[No Abstract] [Full Text] [Related]
28. Skin and Metabolic Syndrome: An Evidence Based Comprehensive Review.
Fatima F; Das A; Kumar P; Datta D
Indian J Dermatol; 2021; 66(3):302-307. PubMed ID: 34446955
[TBL] [Abstract][Full Text] [Related]
29. Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.
Wolk K; Sabat R
Rev Endocr Metab Disord; 2016 Sep; 17(3):305-317. PubMed ID: 27554109
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome and skin: psoriasis and beyond.
Padhi T; Garima
Indian J Dermatol; 2013 Jul; 58(4):299-305. PubMed ID: 23919003
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
32. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
33. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
[TBL] [Abstract][Full Text] [Related]
34. Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease.
Farzanfar D; Dowlati Y; French LE; Lowes MA; Alavi A
Skin Pharmacol Physiol; 2018; 31(5):246-251. PubMed ID: 29953999
[TBL] [Abstract][Full Text] [Related]
35. Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years.
Descamps V; Mahé E; Maccari F; Begon E; Barthelemy H; Reguiai Z; Bénéton N; Estève E; Chaby G; Ruer-Mulard M; Steiner HG; Thomas-Beaulieu D; Avenel-Audran M; Goujon-Henry C; Sigal ML; Ezzedine K; Beauchet A;
Eur J Dermatol; 2014; 24(3):356-60. PubMed ID: 24979347
[TBL] [Abstract][Full Text] [Related]
36. Psoriasis and the metabolic syndrome.
Gisondi P; Fostini AC; Fossà I; Girolomoni G; Targher G
Clin Dermatol; 2018; 36(1):21-28. PubMed ID: 29241748
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome, inflammation and atherosclerosis - the role of adipokines in health and in systemic inflammatory rheumatic diseases.
Santos MJ; Fonseca JE
Acta Reumatol Port; 2009; 34(4):590-8. PubMed ID: 20852572
[TBL] [Abstract][Full Text] [Related]
38. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
[TBL] [Abstract][Full Text] [Related]
39. Effects of Zinc Supplementation on Inflammatory Skin Diseases: A Systematic Review of the Clinical Evidence.
Dhaliwal S; Nguyen M; Vaughn AR; Notay M; Chambers CJ; Sivamani RK
Am J Clin Dermatol; 2020 Feb; 21(1):21-39. PubMed ID: 31745908
[TBL] [Abstract][Full Text] [Related]
40. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases.
Francisco V; Ruiz-Fernández C; Pino J; Mera A; González-Gay MA; Gómez R; Lago F; Mobasheri A; Gualillo O
Biochem Pharmacol; 2019 Jul; 165():196-206. PubMed ID: 30910694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
